VERU INC. Property, Plant and Equipment
VERU INC. (VERU) had Property, Plant and Equipment of $280.23 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-10
- 2026-06-30: Property, Plant and Equipment, Net $280.23K.
- 2026-03-31: Property, Plant and Equipment, Net $308.42K.
- 2025-12-31: Property, Plant and Equipment, Net $336.62K.
- 2025-09-30: Property, Plant and Equipment, Net $364.81K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $280.23K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $308.42K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $336.62K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $364.81K 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $393.38K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $422.71K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $452.04K 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $481.37K 10-K · filed 2025-12-17 | $1.28M 10-K · filed 2024-12-16 |
| 2024-06-30 | $1.49M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.53M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.56M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $1.65M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $1.49M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $1.52M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.43M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $1.19M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $1.08M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.03M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $869.44K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $592.60K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $392.01K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $271.17K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $288.00K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $312.69K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $315.46K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $332.36K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $336.17K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $351.89K 10-K · filed 2020-12-10 | |
| 2019-06-30 | $314.69K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $320.80K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $362.00K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $404.55K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $465.79K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $469.21K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $513.22K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $555.54K 10-K · filed 2018-12-13 | |
| 2017-06-30 | $672.30K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $735.89K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $798.25K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $825.09K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $916.21K 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $1.02M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $1.13M 10-Q · filed 2016-02-02 | |
| 2015-09-30 | $1.24M 10-K · filed 2016-12-12 | |
| 2015-06-30 | $1.35M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $1.37M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $1.47M 10-Q · filed 2015-02-03 | |
| 2014-09-30 | $1.60M 10-K · filed 2015-12-02 | |
| 2014-06-30 | $1.75M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $1.89M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $2.03M 10-Q · filed 2014-02-03 | |
| 2013-09-30 | $2.09M 10-K · filed 2014-12-02 | |
| 2013-06-30 | $2.22M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $2.35M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $2.45M 10-Q · filed 2013-01-30 | |
| 2012-09-30 | $2.35M 10-K · filed 2013-12-03 | |
| 2012-06-30 | $2.29M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $2.03M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $1.96M 10-Q · filed 2012-01-31 | |
| 2011-09-30 | $1.98M 10-K · filed 2012-12-04 | |
| 2011-06-30 | $2.08M 10-Q · filed 2011-08-05 | |
| 2010-09-30 | $2.40M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |